CPT for Offenders With SUD

Summary

This study will evaluate the comparative effectiveness of Therapeutic Education System (TES), a computer-based, psychosocial treatment program, relative to standard care when offered to individuals with substance use disorders in prison settings. The study will assess the comparative effectiveness of these interventions primarily by examining changes in: (1) substance use (e.g., weeks of abstinence), (2) HIV risk behavior (evaluated as both sex-related and drug-related HIV risk behavior) and (3) reincarceration rates. The study will also examine the extent to which these interventions improve psychosocial functioning (e.g., employment, health, and psychological status) and quality of life, and promote relevant skills acquisition (e.g., improve communication skills, reduce "criminal thinking"). The investigators predict significantly better outcomes for E vs. C due to TES' research-based content and use of proven informational technologies.

Conditions

• Computer-assisted, Evidence-based Psychosocial Intervention
• for Substance Abuse Treatment

Interventions

BEHAVIORAL

Therapeutic Education System (TES)

Therapeutic Education System (TES) is an interactive, computer-based, psychosocial treatment program. TES is theoretically grounded in evidence-based psychosocial treatments (Community Reinforcement Approach and Cognitive Behavioral Therapy).

BEHAVIORAL

Standard Care

Psycho-educational and psycho-social approaches to substance use disorders (commonly offered in prison settings) delivered by counselors in group formats.

Sponsors & Collaborators

• University of California, Los Angeles

  collaborator OTHER

• Temple University

  collaborator OTHER

• University of Kentucky

  collaborator OTHER

• University of Miami

  collaborator OTHER

• National Institute on Drug Abuse (NIDA)

  collaborator NIH

• National Development and Research Institutes, Inc.

  lead OTHER

Principal Investigators

• Stan Sacks, PhD · National Development & Research Institutes

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2009-09-30

Primary Completion

2011-08-31

Completion

2012-08-31

Countries

• United States

Study Locations